Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients.
Journal Information
Full Title: Therap Adv Gastroenterol
Abbreviation: Therap Adv Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology & Hepatology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Camilla de Almeida Martins and Sergio Carlos Nahas have no conflict of interest. Natália Sousa Freitas Queiroz has served as a speaker and advisory board member of Janssen, Takeda, and Abbvie. Carlos Walter Sobrado Junior has served as speaker for Janssen, Sandoz, and Abbvie. Alexandre Sousa Carlos has served as speaker for Janssen and Takeda. Matheus Freitas Cardoso de Azevedo and Aderson Omar Mourão Cintra Damião has served as a speaker for Abbvie, Janssen, and Takeda."
"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."
"Trial registration: 4.254.501 and 2.903.748."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025